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Biodegradation of different synthetic hydrogels made of
polyethylene glycol hydrogel/RGD-peptide modifications: an
immunohistochemical study in rats
Abstract
Aim: The aim of the present study was to investigate the pattern of biodegradation of different
polyethylene glycol (PEG) hydrogel/RGD-peptide modifications in rats. Material and methods: Two
different hydrogels were employed: (i) a combination of four-arm PEG-thiol, M(n)=2.3 kDa, and
eight-arm PEG-acrylate, M(n)=2.3 kDa (PEG1); and (ii) a combination of four-arm PEG-thiol,
M(n)=2.3 kDa, and four-arm PEG-acrylate, M(n)=15 kDa (PEG2). Both PEG1 and PEG2 were either
used alone or combined with a nine amino acid cys-RGD peptide (RGD). A non-cross-linked porcine
type I and III collagen membrane [BioGide((R)) (BG)] served as control. Specimens were randomly
allocated in unconnected subcutaneous pouches separated surgically on the back of 60 wistar rats, which
were divided into six groups (1, 2, 4, 8, 16, and 24 weeks). Specimens were prepared for histological
(tissue integration, foreign body reactions, biodegradation) and immunohistochemical (angiogenesis)
analysis. Results: All materials investigated revealed unimpeded and comparable tissue integration
without any signs of foreign body reactions. While BG exhibited transmembraneous blood vessel
formation at 1 week, all PEG specimens were just surrounded by a well-vascularized connective tissue.
The hydrolytic disruption of PEG1 and PEG1/RGD specimens was associated with an ingrowth of blood
vessels at 4 weeks. Biodegradation times were highest for PEG1 (24 weeks)>PEG1/RGD (16
weeks)>BG (4 weeks)>PEG2=PEG2/RGD (2 weeks). Conclusion: Within the limits of the present
study, it was concluded that (i) all materials investigated revealed a high biocompatibility and tissue
integration, and (ii) hydrogel biodegradation was dependent on PEG composition. To cite this article:
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Abstract 
Herten M., Jung, R.E., Ferrari D., Molenberg A., Hämmerle C.H., Becker J., Schwarz F. 
Biodegradation of different synthetic hydrogels made of polyethylene glycol (PEG). An 
immunohistochemical study in rats. Clin Oral Impl Res. 
Aim: The aim of the present study was to investigate the pattern of biodegradation of 
different polyethylene glycol (PEG) hydrogel/ RGD-peptide modifications in rats. 
Material and methods: Two different hydrogels were employed: i) a combination of 4-arm 
PEG-thiol, Mn = 2.3 kDa, and 8-arm PEG-acrylate, Mn = 2.3 kDa (PEG1), and ii) a 
combination of 4-arm PEG-thiol, Mn = 2.3 kDa, and 4-arm PEG-acrylate, Mn = 15 kDa 
(PEG2). Both PEG 1 and PEG2 were either used alone or combined with a 9 amino acid cys-
RGD peptide (RGD). A non cross-linked porcine type I and III collagen membrane (BG) 
served as control. Specimens were randomly allocated in unconnected subcutaneous pouches 
separated surgically on the back of 60 wistar rats, which were divided into six groups (1, 2, 4, 
8, 16, and 24 weeks). Specimens were prepared for histological (tissue integration, foreign 
body reactions, biodegradation) and immunohistochemical (angiogenesis) analysis.  
Results: All membranes investigated revealed an unimpeded and comparable tissue 
integration without any signs of foreign body reactions. While BG exhibited a 
transmembraneous blood vessel formation at 1 week, all PEG specimens were just surrounded 
by a well vascularized connective tissue. The hydrolytic disruption of PEG1 and PEG1/ RGD 
specimens was associated with an ingrowth of blood vessels at 4 weeks. Biodegradation over 
time was highest for PEG1 (24 weeks) > PEG1/ RGD (16 weeks) > BG (4 weeks) > PEG2 = 
PEG2/ RGD (2 weeks). 
Conclusion: Within the limits of the present study, it was concluded that (i) all membranes 
investigated revealed a high biocompatibility and tissue integration, and (ii) hydrogel 
biodegradation was dependent on PEG composition. 
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Introduction 
In recent years, a variety of different membrane materials have been successfully used for 
guided bone regeneration (GBR) procedures, ranging from non-resorbable materials such as 
expanded polytetrafluorethylene (e-PTFE) to bioabsorbable membranes composed of dura-
mater, polylactic acid, polyglycolic acid and polyurethane (Greenstein & Caton 1993). In 
general, a material which is used as a barrier for GBR procedures has to meet certain design 
criteria to provide for biocompatibility, tissue integration, cell-occlusivity, nutritient transfer, 
space making ability and also ease of use in the clinic (Hardwick et al. 1994; Hammerle & 
Jung 2003). Since ePTFE membranes were associated with potential clinical drawbacks such 
as the need for a second surgery to retrieve the barrier as well as bacterial colonization in case 
of premature exposure (Selvig et al. 1992; Tempro & Nalbandian 1993; Hardwick et al. 
1994), nowadays, most investigations focused on the use of products derived from type I and 
type III porcine or bovine collagen (Bunyaratavej & Wang 2001). Indeed, some advantageous 
properties of collagen over other materials include hemostatic function, allowing early wound 
stabilization, chemotactic properties to attract fibroblasts, and semipermeability, facilitating 
nutritient transfer (Postlethwaite et al. 1978; Rothamel et al. 2005; Schwarz et al. 2006). 
However, a major drawback of native collagen is the fast biodegradation by the enzymatic 
activity of macrophages, polymorphonuclear leucocytes and periodontopathic bacteria 
resulting in a poor membrane resistance to collapse thus compromising the secluded wound 
area (Sela et al. 2003; Rothamel et al. 2005). Even though chemical and enzymatical cross-
linking of bovine and porcine derived collagen types I and III resulted in a prolonged 
biodegradation, these procedures were also associated with pronounced foreign body 
reactions as well as a decreased tissue integration, and transmembraneous vascularization 
(Rothamel et al. 2004; Rothamel et al. 2005; Schwarz et al. 2006; Schwarz et al. 2007). 
Moreover, from a clinical point of view, all prefabricated barrier membranes require an 
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adaptation to the individual defect situation, thus impeding their application at sites that are 
difficult to reach. In order to overcome some of these problems, an in situ gelling hydrogel 
composed of two polyethylene glycol (PEG) components was recently suggested as a new 
material for GBR procedures (Jung et al. 2006). In particular, PEG components were proven 
to be highly biocompatible, cell-occlusive, and biodegradable, thus meeting important criteria 
required to serve as a barrier membrane (Working et al. 1997; Jung et al. 2006; Wechsler et 
al. 2007). Moreover, tissue integration of PEG hydrogels might be optimized by the addition 
of an arginine-glycine-aspartic acid (RGD) sequence, which is recognized by many cell types 
important for wound healing including macrophages, fibroblasts, lymphocytes, platelets, and 
endothelial cells through the interaction with extracellular membrane integrin receptors 
(Muller et al. 1995; Ruoslahti 1996). So far, RGD modified PEG, containing covalently 
bound peptides of the parathyroid hormone, was proven to enhance bone regeneration on a 
level equivalent to autogeneous bone (Jung et al. 2007a; Jung et al. 2007b). The principle of 
in situ hydrogel formation is based on the crosslinking of two PEG compounds via their 
reactive endgroups. The crosslinking reaction proceeds fast and selectively at physiological 
pH and temperature, yielding a network of hydrolysable ester linkages (Elbert et al. 2001). 
Even though hydrolysis is mainly dependent on pH and temperature, its rate may also be 
influenced by the composition of the PEG components. So far however, there are virtually no 
data available reporting on the biodegradation of different PEG modifications.  
Therefore, the aim of the present study was to immunohistochemically investigate the pattern 
of tissue integration, transmembraneous angiogenesis, and subsequently biodegdaration of 
different PEG hydrogel/ RGD-peptide modifications in rats. 
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Material and Methods 
Animals 
Sixty albino rats of the wistar strain (age 3.0 ± 0.5 months, weight 350 ± 20 g) were used in 
the study. Animal selection, management, and surgery protocol were approved by the Animal 
Care and Use Committee of the Heinrich Heine University and the Bezirksregierung 
Düsseldorf. The animals were divided into six groups (1, 2, 4, 8, 16, and 24 weeks), including 
ten rats each. During the experiment, the animals were fed ad libitum with standard laboratory 
food pellets.  
 
PEG/ RGD modifications 
Hydrogels were formed in slightly basic aqueous buffer by end linking multi-arm PEG-thiol 
and multi-arm PEG-acrylate molecules through a highly selective Michael type addition 
reaction between the acrylate and thiol endgroups (Elbert et al. 2001). Two different 
hydrogels were employed: i) a combination of 4-arm PEG-thiol, Mn = 2.3 kDa, and 8-arm 
PEG-acrylate, Mn = 2.3 kDa (PEG1), and ii) a combination of 4-arm PEG-thiol, Mn = 2.3 
kDa, and 4-arm PEG-acrylate, Mn = 15 kDa (PEG2) (all from Nektar Therapeutics, 
Huntsville AL, USA). The buffer system was triethanol-amine/ HCl in endotoxin-free water, 
containing carboxymethyl cellulose (Cekol 10 000, Noviant, Nijmegen, Netherlands, PhEur) 
in order to control the flow of the material before gelation had completed. The total PEG 
contents were 24 and 8 wt%, respectively, for systems i and ii, corresponding to the 
equilibrium concentrations in PBS at 37°C. 
Sample preparation took place in a laminar flow bench, using autoclaved equipment. 
Equimolar amounts (with respect to their endgroups) of sterile filtered PEGs were packed in 
glass syringes. Buffer solutions were packed in plastic syringes with female Luer lock and 
autoclaved. RGD was attached covalently to the PEG hydrogels by adding a 9 amino acid 
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cys-RGD peptide (Bachem, Bubendorf, Switzerland). For PEG1, the cys-RGD peptide was 
pre-reacted with 15 kDa 4-arm PEG-acrylate (in 0.1 M triethanolamine, cysteine:acrylate ratio 
1:4) in order to increase the distance between the RGD sequence and the crosslinking points 
of the hydrogel network. In both cases the concentration of cys-RGD was 1.0 mmol/ ml of 
hydrogel. PEGs, buffer, and (if applicable) cys-RGD were mixed by syringe-to-syringe 
mixing, after which the gelling mixture was cast between two glass plates separated by a 0.6 
mm thick distance ring. Gelation was complete after a few minutes and discs with a diameter 
of 6 mm were cut out with a biopsy punch and placed in the wells of a 24 well plate. Each 
hydrogel disc was washed 5 times with 1 ml of endotoxin-free water in order to remove the 
buffer salts. The moist hydrogels were kept in the sealed well plate at 2-8°C until 
implantation. 
A non-cross-linked, bilayered porcine type I and III collagen membrane (BioGide®, Geistlich 
Biomaterials, Wolhusen, Switzerland) (BG) served as control. Each specimen was trimmed to 
an uniform size (diameter 6 mm).  
Ten minutes prior to implantation, all specimens were rehydrated in sterile 0.9 % 
physiological saline (Braun, Melsungen, Germany). 
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Surgical procedure 
The animals were anesthesized by intraperiotoneal injection of 7.5 mg/kg ketamine 
(Ketanest®, Pfizer Pharma GmbH, Karlsruhe, Germany) and 5 mg/kg xylazine (Rompun®, 
Bayer HealthCare, Leverkusen, Germany). An area of approximately 8 cm in length and 4 cm 
in width was depilated on the back of each rat using an electric shaver and a razor blade. 
Following disinfection with polyvidone iodine (Betaisodona®, Mundipharma, Limburg/Lahn, 
Germany), a skin incision was made right paramedian along the vertebral column followed by 
the separation of four unconnected subcutaneous pouches. The specimens were randomly 
allocated in the resulting 240 pouches, including ten rats (n=40 pouches) per observation 
period (Rothamel et al. 2005; Schwarz et al. 2006) (Fig. 1). Accordingly, each specimen was 
tested eightfold per observation point. Randomization was performed according to a computer 
generated protocol (RandList®, DatInf GmbH, Tübingen, Germany). Primary wound closure 
was achieved using subcutaneous horizontal mattress 5-0 and consecutive cutaneous 3-0 
resorbable sutures (Vicryl, Ethicon, Johnson & Johnson, Norderstedt, Germany).  
Postoperative analgesia (4.5 mg/kg carprofene; Rimadyl®, Pfizer Pharma GmbH, Karlsruhe, 
Germany) was administered subcutaneously immediately after surgery, as well as 1, 2, and 3 
days postoperatively.  
 
Animal sacrification and retrieval of specimens 
The animals were killed in a carbon dioxide euthanasia chamber after 1, 2, 4, 8, 16, and 24 
weeks of healing, respectively. Residues of the specimens were removed with the surrounding 
connective tissue and fixed in 10% neutral buffered formalin solution for 4-7 days.  
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Histological preparation 
The specimens were dehydrated using ascending grades of alcohol and xylene, infiltrated, and 
embedded in methylmethacrylate (MMA, Technovit 9100 NEU, Heraeus Kulzer, Wehrheim, 
Germany) for nondecalcified sectioning. During this procedure, any negative influence of 
polymerisation heat was avoided due to a controlled polymerization in a cold atmosphere (-4 
°C). After 20 hours the specimens were completely polymerized. Serial sections (Exakt®, 
Apparatebau, Norderstedt, Germany) were prepared along to the long-axis of the specimens, 
resulting in 6-8 sections of approximately 200 µm in thickness each (Donath 1985). 
Subsequently, all specimens were glued with acrylic cement (Technovit 7210 VLC, Heraeus 
Kulzer, Wehrheim, Germany) to opaque plexiglas and ground to a final thickness of 
approximately 45 µm. One part of the sections was scheduled for histomorphometrical 
analysis and stained with Masson Goldner Trichrome (MG), while the other part of the 
sections was prepared for immunohistochemical labelling.  
 
Immunohistochemical labelling 
For immunohistochemistry all tissue section were deplasted in xylol (2x 30 min) followed by 
a treatment in 2-methoxyethylacetate (2x 20 min) and acetone (2x 5 min). After rehydration in 
phosphate buffered saline (PBS), antigen unmasking was performed by incubating the slides 
for 15 min in trypsin (0.05% in PBS, PAA Laboratories GmbH, Pasching, Austria) at 37°C. 
After washing with PBS the activity of endogenous peroxidase was quenched with 0.9 % 
hydrogen peroxide in PBS for 10 min at room temperature, the specimens were washed and 
non-specific binding sites were blocked with a blocking solution for 30 min 
(DakoCytomation, Hamburg, Germany). The primary mouse monoclonal antibody to 
transglutaminase II (TG) (1:40 dilution, Acris Antibodies GmbH, Hiddenhausen, Germany) 
and the corresponding unspecific antibody (mouse IgG1), respectively as negative control 
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were applied to tissue sections in a humidified chamber and incubated over night at 8°C. The 
slides were washed in PBS and incubated with secondary biotinylated anti-mouse antibody 
(1:50 dilution, Dako) for 90 min at room temperature. After washing in PBS the presence of 
antibody-antigen complexes was visualized using a streptavidin-peroxidase solution (1:250 
dilution, Dako) and AEC (3-amino-9-ethylcarbazole) as the chromogen (Dako). 
 
Histological analysis 
Histomorphometrical analyses as well as microscopic observations were performed by one 
experienced investigator masked to the specific experimental conditions. For image 
acquisition a color CCD camera (Color View III, Olympus, Hamburg, Germany) was 
mounted on a binocular light microscope (Olympus BX50, Olympus, Hamburg, Germany). 
Digital images (original magnification x 200) were evaluated using a software program 
(analySIS FIVE docu®, Soft Imaging System, Münster, Germany).  
Thickness of the membrane specimens (MT) was measured linearly at 9 fields selected at 
random. Additionally, the following parameters were evaluated descriptively: tissue 
integration, pattern of biodegradation, angiogenesis, foreign body reactions (i.e. presence of 
multinucleated giant cells). 
 
Statistical Analysis 
A software package (SPSS 15.0, SPSS Inc., Chicago, IL, USA) was used for the statistical 
analysis. Mean values and standard deviations were calculated for membrane thickness of 
each group. Analysis of variance (ANOVA) and post-hoc testing using Bonferroni`s 
correction for multiple comparisons was used for comparisons within groups at each time 
point compared to baseline (1 week scores). Results were considered statistically significant at 
P<0.05.  
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Results 
The postoperative healing was uneventful in all animals. No complications such as allergic 
reactions, abscesses or infections were observed throughout the whole study period.  
 
Histomorphometric analysis  
The mean values of MT for each group at 1, 2, 4, 8, 16, and 24 weeks are presented in Figure 
2. In particular, at 2 weeks, histomorphometric analysis revealed a significant decrease of MT 
in both PEG2 and PEG2/ RGD groups (P<0.001; respectively). In contrast, MT of BG, PEG1 
and PEG1/ RGD seemed to be unchanged compared to the respective 1 week values (P>0.05; 
respectively). After 4 weeks of healing, histomorphometric analysis failed to identify any 
residues of PEG2 and PEG2/ RGD specimens. While MT of PEG1 and PEG1/ RGD 
membranes seemed to be unchanged compared to baseline (P>0.05; respectively), respective 
values were significantly reduced for BG (P<0.001). At 8 weeks, a significant reduction of 
mean MT was observed for BG (P<0.001) and PEG1/ RGD specimens (P<0.05), while 
respective values remained nearly unchanged in the PEG1 group (P>0.05).  
After 16 and 24 weeks of healing, both PEG1 and PEG1/ RGD specimenes revealed a 
pronounced reduction of mean MT (P<0.001), while thickness of BG residues seemed to be 
on a level equivalent to that observed after 8 weeks (Figure 2).  
 
Histological/ Immunohistochemical analysis 
One week specimens 
There were obvious differences noted for the structure of BG, PEG1/2, and PEG1/2 / RGD 
membrane specimens. In particular, BG seemed to be structured like an interconnective 
porous system (Figs. 3a and b). In contrast, all PEG modifications revealed a tight membrane 
structure without any cognizable interstices (Figs. 3c-f). However, all PEG specimens 
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exhibited some localized artifacts probably caused during histological processing. While 
PEG1 modifications appeared to be more densely and homogeneously structured than 
respective PEG2 membranes, there was no structural difference noted between PEG1 and 
PEG1/ RGD groups. In contrast, histological analysis revealed some dissolved areas within 
the membrane body of PEG2/ RGD modified specimens. In particular, these areas were 
heterogeneous in structure, and characterized by a decrease in material density and 
subsequently a rupture of the membrane body (Fig. 3f). In general, all specimens investigated 
exhibited an unimpeded tissue integration. While BG revealed a localized ingrowth of 
adjacent fibroblasts inside its porous system, the subcutaneous connective tissue was also 
completely and homogeneously attached to all PEG and PEG/ RGD surfaces.  In some 
localized areas, both PEG and PEG/ RGD specimens were separated from the adjacent 
connective tissue by a split. In general, however, initial tissue integration was comparable for 
all PEG and PEG/ RGD modified specimens (Figs. 3c-f). In all groups, immunohistochemical 
analysis revealed a well vascularized subcutaneous connective tissue zone, showing a 
pronounced TG antigen reactivity within the endothelium of blood vessels. However, obvious 
differences were noted with respect to the initial vascularization of the membrane specimens 
investigated. While newly formed blood vessels had homogeneously invaded and sprouted 
within the external, middle and internal layers of BG, all PEG and PEG/ RGD modifications 
inhibited early transmembraneous angiogenesis (Figs. 3b and f). Histological analysis failed 
to reveal any infiltration of inflammatory cells in the connective tissue adjacent to the external 
surface of each specimen investigated.   
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Two week specimens 
After two weeks of healing, histological analysis revealed a nearly complete vascularization 
and organization of BG, PEG2, and PEG2/ RGD modified specimens (Figs. 4a and b). While 
the matrix of BG still appeared to be intact, both PEG2 and PEG2/ RGD membrane 
specimens were homogeneously dissolved and substituted by a dense and well vascularized 
connective tissue (Fig. 4c). Some localized residues of the PEG2 and PEG2/ RGD specimens 
were only observed occasionally. In these areas, however, there were no signs of any 
inflammatory cells. In contrast, both PEG1 and PEG1/ RGD specimens revealed a tissue 
integration similar to that observed after 1 week of healing. In particular, both types of 
membranes were predominantly embedded in the subcutaneous connective tissue but also 
revealed some localized areas of tissue disintegration which were clearly demarcated by a 
split (Fig. 4d). In some well defined peripheral areas, PEG1/ RGD modified specimens 
exhibited first signs of a dissolution of the matrix, which was also accompanied by the 
ingrowth of adjacent fibroblasts (Fig. 4e). Even though TG antigen reactivity appeared to be 
pronounced within the adjacent connective tissue, there were no signs of any vascularization 
of the membrane body noted in both PEG1 and PEG1/ RGD groups (Fig. 4f).  
 
Four week specimens 
After four weeks, histological analysis revealed a homogeneous fibrous organisation of BG, 
resulting in a nearly complete biodegradation of this membrane. In particular, the surrounding 
connective tissue had completely merged into the former matrix of BG (Fig. 5a). Similarly, 
histological observation failed to identify any residues of both PEG2 and PEG2/ RGD 
specimens. In contrast, the membrane bodies of PEG1 and PEG1/ RGD specimens were still 
intact (Figs. 5b and c). In particular, the PEG1 group appeared to be unaltered with respect to 
membrane structure, tissue integration, vascularization, and organization by fibroblasts (Fig. 
  
 
13 
5b). However, within the same period of time, PEG1/ RGD modified specimens generally 
exhibited an ongoing dissolution, particularly at the peripheral compartment of the membrane. 
These areas were characterized by a decrease in material density and expanded parts of the 
membrane. The resulting large interstices were homogeneously invaded by a well 
vascularized connective tissue which appeared to be in close contact to the PEG1/ RGD 
material (Figs. 5c and d). Histological analysis failed to identify any inflammatory cells 
within the connective tissue adjacent to both PEG1 and PEG1/ RGD specimens. 
 
Eight week specimens 
After eight weeks, the entire biodegradation of BG resulted in a complete substitution of the 
former matrix by a dense and well vascularized connective tissue. All PEG1 and PEG1/ RGD 
modified specimens also revealed ongoing sings of biodegradation. In particular, both types 
of membranes exhibited a dissolution within the central part of the matrix. This was 
particularly true for PEG1/ RGD specimens, resulting in a disruption of the membrane body 
into numerous fragments (Figs. 6a and b). These fragments revealed a longitudinal alignment 
and were most commonly surrounded by a well attached and vascularized connective tissue 
(Fig 6c). Some localized multinucleated giant cells could be identified in the membrane body 
of both PEG1 and PEG1/ RGD modified specimens (Fig. 6d). 
 
Sixteen week specimens 
In the PEG1 group, biodegradation was mainly characterized by a dissemination of membrane 
residues towards the adjacent connective tissue. In particular, the residual fragments were 
markedly reduced in size and had assumed a round shape. While the loose peripheral 
membrane residues were well integrated into the surrounding connective tissue, the central 
fragments appeared to be more condensed. Moreover, these central residues revealed a 
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heterogeneous density (i.e. the more central the higher the density). However, some 
fibroblasts had also started to organize the loose peripheral areas of the central fragments, thus 
connecting the opposite margins of the adjacent connective tissue (Fig. 7a). There were no 
signs of any multinucleated giant cells. In contrast, PEG1/ RGD membrane specimens were 
homogeneously dissolved and substituted by a dense and well vascularized connective tissue 
Some localized residues of the specimens were only observed occasionally but appeared to be 
completely integrated into the surrounding connective tissue (Fig. 7b).     
  
Twenty-four week specimens 
While there were no residues identifiable in the PEG1/ RGD group, the area of residual PEG1 
fragments was markedly reduced after 24 weeks of healing. In particular, this area still 
revealed a central core of densely structured PEG1 fragments (Fig. 8a). This core area, 
however, was surrounded by dissolved and loosely structured PEG1 remnants, which were 
completely and homogeneously organized by ingrowing fibroblasts and blood vessels. There 
were no signs of any multinucleated giant cells (Fig. 8b). 
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Discussion 
The present study was designed to histologically evaluate tissue integration, vascularization, 
and subsequently the pattern of biodegradation of different PEG hydrogel modifications and a 
native collagen membrane after subcutaneous implantation in rats. In this context, it must be 
emphasized that the surgical procedure was in accordance with previous studies reporting on 
biodegradation of native and cross-linked collagen membranes employing the same model 
(Rothamel et al. 2005; Schwarz et al. 2006; Wechsler et al. 2007). Within its limts, the present 
results have indicated that all PEG hydrogel modifications investigated revealed a high 
biocompatibility, which was clearly identifiable by an undisturbed initial tissue integration as 
well as the lack of inflammatory reactions in the adjacent connective tissue. Similar 
histological characteristics were also observed for BG specimens, which is in accordance with 
previous experimental studies. In particular, an undisturbed tissue integration was commonly 
observed for the native BG membrane, whereas cross-linking of bovine and porcine derived 
collagen types I and III was associated with pronounced foreign body reactions and a 
decreased tissue integration. However, it was observed that MT of BG was also markedly 
reduced between 2 and 4 weeks following implantation, while biodegradation of cross-linked 
collagen membranes was significantly prolonged (Rothamel et al. 2005; von Arx et al. 2005; 
Schwarz et al. 2006; Schwarz et al. 2007). One possible explanation for the reduced initial 
tissue integration of modified collagen was due to a decreased membrane biocompatibility 
caused by the specific cross-linking techniques (Speer et al. 1980; Rothamel et al. 2004). 
Based on these findings, it might be concluded that all PEG modifications investigated in the 
present study exhibited a biocompatibility equivalent to that previously noted for native 
collagen membranes. Similar results were also reported by Wechsler et al. (2007) following 
implantation of polyvinyl alcohol/ fibrin sponges embedded in a PEG1 hydrogel 
subcutaneously in rats. In particular, at 3 and 6 months, only minor macrophage infiltration 
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could be detected at the interface between implant and host tissue. Similarly, the present 
results have indicated that only a few localized multinucleated giant cells could be identified 
in the membrane body of PEG1 and PEG1/ RGD modifications particularly after 8 weeks of 
healing. However, it was also observed that the specimens were surrounded by a thin cell-
containing capsule and started to disintegrate after 6 months of healing (Wechsler et al. 2007). 
This observation is also in agreement with the present results, since all PEG hydrogel 
modifications revealed some localized areas of tissue disintegration which were clearly 
demarcated by a split. At initial observation periods of 1 and 2 weeks, this seemed to be 
particularly true for both PEG2 modifications. One possible explanation for tissue 
disintegration over time might be due to the specific pattern of degradation reported for PEG 
hydrogels. In particular, the process of hydrolysis is initially associated with an uptake of 
water and subsequently a swelling and disintegration of the material. However, hydrolysis 
also results in a loss of PEG molecules and membrane degradation over time (Elbert et al. 
2001; Wechsler et al. 2007). When interpreting the present results, it was observed that 
hydrolysis and subsequently biodegradation markedly differed between PEG1 and PEG2 
specimens. While in the PEG2 group, a nearly complete organization of the matrix was 
observed at 2 weeks, the PEG1 modification revealed a significant reduction of MT merely 
after 16 weeks of healing. Similar results were also reported in previous experimental studies 
(Jung et al. 2006; Wechsler et al. 2007). In particular, Jung et al. (2006) reported that PEG1 
membranes could still be identified at 4 weeks following placement in rabbit calvarial defects. 
Moreover, the specimens appeared to be thicker compared with the time of application, 
probably as a result of water uptake during initial stages of hydrolysis. Wechsler et al. (2007) 
also reported on a prolonged hydrolysis of PEG1 specimens in rats, since even a barrier 
function seemed to be maintained for up to 6 months. In this context, it is important to realize 
that the addition of an RGD sequence resulted in a faster hydrolysis of PEG1 specimens. This 
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was particularly true for PEG1/ RGD specimens investigated after 16 and 24 weeks of 
healing. Even though RGD has previously been found to promote adhesion and migration of 
fibroblasts (Muller et al. 1995; Ruoslahti 1996), the present study revealed a comparable 
tissue integration for both PEG1 and PEG1/ RGD membranes (Stimmt das wirklich, wir 
hatten doch immer eine zustätzliche Zellschicht bei den RGD Gruppe. Dies wäre eine 
wichtige Aussage für zukünftige Studien) In this context, however, it must be realized that a 
precise comparison of tissue integration in all PEG groups was indeed impeded by membrane 
disintegration due to hydrolysis. When interpreting the present results, it was also observed 
that the pattern of angiogenesis markedly differed among the membranes investigated. In this 
context, it must be emphasized that angiogenesis provides osteogenic cells which have been 
observed to arise from pericytes adjacent to small blood vessels in connective tissue (Long et 
al. 1995; Rickard et al. 1996; Reilly et al. 1998). Accordingly, the organization of the wound 
area by proliferating blood vessels was considered to be of crucial importance for the process 
of bone regeneration. Therefore, angiogenesis was investigated by the use of primary mouse 
monoclonal antibodies to TG, an enzyme that stabilizes the structures of tissues by covalently 
ligating extracellular matrix molecules. Within its limitations, the present results have 
indicated that BG exhibited a homogeneous invasion and sprouting of newly formed blood 
vessels within its external, middle and internal layers after 1 week of healing. However, it was 
also observed that the fast transmembraneous vascularization particularly of BG seemed to be 
responsible for the premature biodegradation of this membrane (Schwarz et al. 2008). In 
contrast, all PEG modifications exhibited a pronounced TG antigen reactivity within the 
adjacent connective tissue, however, without any signs of transmembraneous angiogenesis 
during initial stages of wound healing. However, the ingrowth of a well vascularized 
connective tissue was commonly observed when a disruption of the membrane body into 
numerous fragments took place as a result of hydrolysis at later stages of wound healing. In 
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the PEG1/ RGD group, this was commonly observed at 4 weeks (Waren es bei PEG1/RGD 
nicht eher 8 Wochen?), while PEG1 specimens exhibited a transmembraneous blood vessel 
formation after 16 weeks of healing. So far, the impact of early transmembraneous 
angiogenesis is still rather unknown. However, most recent results from an experimental 
study performed in dogs have indicated, that collagen membranes enabling an early 
transmembraneous angiogenesis supported bone regeneration in a peripheral compartment of 
the wound area at dehiscence-type defects (Schwarz et al. 2008). On the other hand, most 
recent studies also reported on a predictable outcome of bone regeneration following 
application of either PEG1 membranes or PEG2/ RGD modified matrices in different types of 
defect configurations (Jung et al. 2006; Jung et al. 2007b). 
Within the limits of the present study, it was concluded that (i) all membranes investigated 
revealed a high biocompatibility and tissue integration, and (ii) hydrogel biodegradation was 
dependent on PEG composition. 
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Figure legends 
 
Figure 1. Specimens were randomly allocated in unconnected subcutaneous 
pouches separated surgically on the back of the rats (a). PEG1 (b). 
PEG2+RGD (c), BG (d). 
 
Figure 2. Membrane thickness (mm) ± SD as evaluated 1, 2, 4, 8, 16, and 24 
weeks following implantation (n=60 rats). The stars indicate 
statistically significant differences within groups at each time point 
compared to baseline (1 week scores). (ANOVA; * P<0.05, *** 
P<0.001). 
 
Figure 3. Representative histological views after 1 week of healing.  
 BG revealed an interconnective porous system like structure (a) (MG, 
original magnification x200), which was homogeneously invaded by 
newly formed blood vessels (arrow heads) originating from the adjacent 
connective tissue (b) (TG, original magnification x200). 
 All PEG modifications revealed a tight membrane structure without any 
cognizable interstices. In general, initial tissue integration of PEG1 (c), 
PEG1/ RGD (d), PEG2 (e), and PEG2/ RGD (f) modified specimens 
was comparable to that noted for BG (TG, original magnification x200). 
PEG2/ RGD modified specimens (f) revealed first signs of matrix 
dissolution (arrow heads indicate blood vessel formation in the adjacent 
connective tissue) (TG, original magnification x 200). 
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Figure 4. Representative histological views after 2 weeks of healing.  
   While the matrix of BG (a) (MG, original magnification x200) still 
   appeared to be intact, both PEG2 (b) (MG, original magnification x200) 
   and PEG2/ RGD (c) (TG, original magnification x100) specimens were 
   homogeneously dissolved and substituted by a dense and well   
   vascularized (arrow heads) connective tissue.  
   Both types of PEG1 membranes revealed some localized areas of tissue 
   disintegration which were clearly demarcated by a split (d) (PEG1, MG, 
   original magnification x100).  
   PEG1/ RGD modified specimens exhibited first signs of a dissolution of 
   the matrix (arrow heads) (e) (MG, original magnification x200). In 
   both PEG1 and PEG1/ RGD  groups, TG antigen reactivity (arrow 
   heads) was restricted to the adjacent connective tissue (PEG1, TG, 
   original magnification x100).  
 
Figure 5. Representative histological views after 4 weeks of healing.  
   Homogeneous fibrous organisation of BG, resulting in a nearly  
   complete biodegradation of this membrane (a) (MG, original  
   magnification x200).  
   PEG1 specimens appeared to be unaltered with respect to membrane 
   structure, tissue integration, vascularization, and organization by  
   fibroblasts (b) (MG, original magnification x100). 
   PEG1/ RGD modified specimens generally exhibited an ongoing  
   dissolution, resulting in large interstices (c) (MG, original magnification 
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   x100) which were homogeneously invaded by a well vascularized 
   (arrow heads) connective tissue (d) (TG, original magnification x200).  
 
Figure 6. Representative histological views after 8 weeks of healing.  
   Both PEG1 (a) and PEG1/ RGD (b) modified specimens exhibited a 
   disruption of the membrane body into numerous fragments (MG,  
   original magnification x100). These fragments were most commonly 
   surrounded by a well attached and vascularized (arrow heads)  
   connective tissue (c) (TG, original magnification x400). Some localized 
   multinucleated giant cells could be identified in the membrane body of 
   both types of specimens (d) (MG, original magnification x500). 
 
Figure 7. Representative histological views after 16 weeks of healing.  
   In the PEG1 group (a), residual fragments (arrows) were markedly 
   reduced in size and had assumed a round shape. Some fibroblasts had 
   started to organize the loose peripheral areas of the central fragments 
   (MG, original magnification x100).  
   PEG1/ RGD specimens (b) were homogeneously dissolved (arrow 
   heads) and substituted by a dense and well vascularized connective 
   tissue (MG, original magnification x200).  
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Figure 8. Representative histological views after 24 weeks of healing.  
   A central core of densely structured PEG1 fragments (arrow heads) was 
   surrounded by dissolved and loosely structured PEG1 remnants (a)
   (MG, original magnification x100), which were completely and  
   homogeneously organized by ingrowing fibroblasts (arrow heads) and 
   blood vessels (b) (MG, original magnification x200). 
 
Figures 1 – 8. 
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